|
Palbociclib shows promise in patients with hormone-resistant breast cancer
Targeted therapy drug recently approved by FDA for use in newly metastatic breast cancer patientsPalbociclib, an investigational oral medication that works by blocking molecules responsible for...
More... |
| All times are GMT -7. The time now is 01:38 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021